Skip to main content

News
Features
Voices
Education
Your Journey
Glossary
Subscribe

The FNAIT Journey: Sharing

Explore insights and strategies for managing FNAIT long-term.

Diagnosis Seekers
Newly Diagnosed
On Your Way
Long-Term Living

Treatments Rallybio’s potential FNAIT treatment enters Phase II
Treatments J&J’s nipocalimab trial for FNAIT set to begin phase 3
Science, Treatments Rallybio’s novel therapy successfully prevents FNAIT in mice
Science Recommendations for preventing ICH in second FNAIT-affected pregnancy
Science FNAIT-affected children may be at greater risk for autism
Science Characteristics of prenatal intracranial hemorrhage due to FNAIT
Science FNAIT’s effect on long-term child development

Previous page Page 1 … Page 11 Page 12 Page 13 Page 14 Page 15 Next page Last page

Learn more about FNAIT

Sign up for the latest news, perspectives, and information about FNAIT.

Your news and information resource for fetal and neonatal alloimmune thrombocytopenia

Search for:

News
Features
Voices
Education
Contribute
About
Staff

Part of the Haymarket Medical Network

Rare Disease Companion (RDC) is a network of news and information websites that supports people living with rare diseases. Through accurate, authentic, and compassionate news coverage, feature-length articles, and patient-friendly educational material, RDC provides insights into living with rare diseases at every point along the patient journey.

Copyright © 2026 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.